SHC (Sotera Health Co) ROC (Joel Greenblatt) %: 25.85% (As of Mar. 2026) — Near Median


SHC Sotera Health Co SHC
74 GF Score
Price $17.93
GF Value $16.33
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sotera Health Co ROC (Joel Greenblatt) %?

Sotera Health Co SHC +1.01% 74 ROC (Joel Greenblatt) % is 25.85% as of Mar. 2026, which is 2% below its 10-year median of 26.39. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.33 (Fairly Valued). The stock has 5 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Sotera Health Co ranks better than 79.62% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sotera Health Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.85%.

The historical rank and industry rank for Sotera Health Co's ROC (Joel Greenblatt) % or its related term are showing as below:

SHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -20.97   Med: 26.39   Max: 34.42
Current: 30.85

During the past 8 years, Sotera Health Co's highest ROC (Joel Greenblatt) % was 34.42%. The lowest was -20.97%. And the median was 26.39%.

SHC's ROC (Joel Greenblatt) % is ranked better than
79.62% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02 vs SHC: 30.85

Sotera Health Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Sotera Health Co  (NAS:SHC) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Sotera Health Co ROC (Joel Greenblatt) % Related Terms


Sotera Health Co ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Sotera Health Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotera Health Co ROC (Joel Greenblatt) % Chart

Sotera Health Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 34.42 -20.97 27.75 26.37 26.49

Sotera Health Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.41 21.48 39.74 36.64 25.85

SHC vs VCYT, RDNT, BLLN: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, Sotera Health Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sotera Health Co ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Sotera Health Co's ROC (Joel Greenblatt) % falls into.


SHC
74GF Score
Sotera Health Co SHC
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotera Health Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(139.329 + 54.375 + 38.148) - (128.977 + 17.999 + 79.415)
=5.461

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(137.256 + 57.494 + 38.008) - (136.939 + 13.741 + 33.776)
=48.302

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Sotera Health Co for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=309.432/( ( (1163.957 + max(5.461, 0)) + (1176.348 + max(48.302, 0)) )/ 2 )
=309.432/( ( 1169.418 + 1224.65 )/ 2 )
=309.432/1197.034
=25.85 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 25.85% mean?
Sotera Health Co (SHC) has a ROC (Joel Greenblatt) % of 25.85% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sotera Health Co and its competitors. This is near median its historical median of 26.39. According to the industry distribution chart, Sotera Health Co ranks #43 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 20.4%.
Is Sotera Health Co's ROC (Joel Greenblatt) % too high?
Sotera Health Co's current ROC (Joel Greenblatt) % of 25.85% is near median its 10-year median of 26.39. Based on the distribution chart, Sotera Health Co ranks #43 out of 211 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's ROC (Joel Greenblatt) % compare to VCYT and RDNT?
According to the Medical Diagnostics & Research industry distribution chart, Sotera Health Co ranks #43 out of 211 companies for ROC (Joel Greenblatt) %. This places Sotera Health Co in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sotera Health Co and its competitors. Sotera Health Co's current ROC (Joel Greenblatt) % is 25.85%, which is near median its own 10-year median of 26.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.33, compared to a current price of $17.93 — trading 9.8% above its estimated fair value. The current ROC (Joel Greenblatt) % is 25.85%, which is near median its 10-year median of 26.39. Sotera Health Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sotera Health Co (SHC), the current ROC (Joel Greenblatt) % is 25.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $17.93 is trading 9.8% above its estimated GF Value™ of $16.33. GuruFocus considers Sotera Health Co to be Fairly Valued.

Key valuation signals for SHC:

  • ROC (Joel Greenblatt) %: 25.85% (near median its 10-year median of 26.39)
  • GF Value™: $16.33 vs. price of $17.93 (9.8% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score

Get the complete analysis for SHC

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.93
Price
$16.33
GF Value